Purification of a highly modified RNA-aptamer Effect of complete denaturation during chromatography on product recovery and specific activity

作者: Philippe Bridonneau , Steve Bunch , Robert Tengler , Ken Hill , Jeff Carter

DOI: 10.1016/S0378-4347(99)00037-7

关键词:

摘要: To evaluate RNA-aptamers as potential drug candidates, efficient and scaleable purification protocols are needed. Because aptamers highly structured rigid molecules, denaturation during the process is a critical aspect to obtain pure active product. A two-step chromatographic procedure was developed purify synthetic anti-VEGF aptamer at preparative scale. reversed-phase step optimized with hydrophobic ion pairing reagent, followed by ion-exchange chromatography in which heat chaotropic salt were used. of presence 2'-modified ribose, conditions had be both steps achieve fully molecule.

参考文章(35)
Fritz Eckstein, Oligonucleotides and analogues : a practical approach IRL Press : Oxford University Press, c1991. ,(1991)
S R Watson, C Bell, M F Kubik, D M Tasset, T Fitzwater, Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. Journal of Immunology. ,vol. 159, pp. 259- 267 ,(1997)
H Tahara, M T Lotze, P D Robbins, S K Narula, T Suzuki, R M Berman, Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. Journal of Immunology. ,vol. 157, pp. 231- 238 ,(1996)
Mark F. Kubik, Andrew W. Stephens, Dan Schneider, Richard A. Marlar, Diane Tasset, High-affinity RNA ligands to human α-thrombin Nucleic Acids Research. ,vol. 22, pp. 2619- 2626 ,(1994) , 10.1093/NAR/22.13.2619
K Jin Kim, Bing Li, Jane Winer, Mark Armanini, Nancy Gillett, Heidi S Phillips, Napoleone Ferrara, None, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature. ,vol. 362, pp. 841- 844 ,(1993) , 10.1038/362841A0
Ralph E. Christoffersen, J. Joseph Marr, Ribozymes as human therapeutic agents. Journal of Medicinal Chemistry. ,vol. 38, pp. 2023- 2037 ,(1995) , 10.1021/JM00012A001
Philippe Bridonneau, Ying-Fon Chang, Dan O'Connell, Stanley C. Gill, David W. Snyder, Lea Johnson, Theodore Goodson,, David K. Herron, David H. Parma, High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2). Journal of Medicinal Chemistry. ,vol. 41, pp. 778- 786 ,(1998) , 10.1021/JM970579K